Stocks and InvestingStocks and Investing
Wed, September 20, 2023
Tue, September 19, 2023
Mon, September 18, 2023
Fri, September 15, 2023

Matt O"Brien Maintained (STAA) at Hold with Decreased Target to $45 on, Sep 15th, 2023


Published on 2024-10-28 06:27:06 - WOPRAI, Matt O'Brien
  Print publication without navigation


Matt O"Brien of Piper Sandler, Maintained "STAAR Surgical Company" (STAA) at Hold with Decreased Target from $50 to $45 on, Sep 15th, 2023.

Matt has made no other calls on STAA in the last 4 months.

There are 4 other peers that have a rating on STAA. Out of the 4 peers that are also analyzing STAA, 3 agree with Matt"s Rating of Hold. Following are those relevant analyst calls for the last 4 months;

Thomas Stephan of "Stifel" Reiterated at Hold and Held Target at $45 on, Wednesday, September 13th, 2023
William Plovanic of "Canaccord Genuity" Downgraded from Strong Buy to Hold and Decreased Target to $48 on, Thursday, August 3rd, 2023
Margaret Kaczor of "William Blair" Downgraded from Buy to Hold on, Wednesday, June 7th, 2023

This is the rating of the analyst that currently disagrees with Matt;

George Sellers of "Stephens & Co." Reiterated at Buy and Held Target at $57 on, Monday, August 14th, 2023